Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (6): 675-680.doi: 10.3736/jcim20070615

• Original Experimental Research • Previous Articles     Next Articles

Protective effect of Huaxia shallot preparation on human umbilical vein endothelial cell injury induced by oxidized low density lipoprotein and its mechanism

Jie-mei Zhang1, Jie Guo1, Xin Tu2, Zhao-hong Shi1, Jian-jun Hao1, Yu-he Ke1, Jiang-feng Guan1, Juan-juan He1   

  1. 1. Unit of Cardiology,Institute of Integrative Medicine,Wuhan First Hospital,Wuhan,Hubei Province 430022,China
    2. Human Genome Research Cent,Life and Technology College,Huazhong University of Science and Technology,Wuhan,Hubei Province 430074,China
  • Online:2007-11-20 Published:2007-11-15

Objective: To observe the protective effect of Huaxia shallot preparation on human umbilical vein endothelial cell (HUVEC) injury induced by oxidized low density lipoprotein (Ox-LDL) in vitro.Methods: Ox-LDL was prepared and identified, and HUVECs were cultured. After 2-hour intervention of different drugs and 24-hour following intervention of Ox-LDL, the number of HUVECs was observed by phase contrast optical microscope and the activity of the HUVECs was observed by methyl thiazolyl tetrazolium (MTT) technique. Superoxide dismutase (SOD) activity and nitric oxide (NO) content were assayed by respective kit. The protein expressions and mRNA levels of peroxisome proliferators activated receptor γ (PPAR-γ) and endothelial nitric oxide synthase (eNOS) were measured by western blot technique and reverse transcription polymerase chain reaction (RT-PCR).Results: Ox-LDL could increase the apoptosis rate of the HUVECs and decrease the NO release as compared with the blank control group (P<0.05). These effects induced by Ox-LDL were all significantly inhibited by Huaxia shallot preparation. It could up-regulate the protein expressions and mRNA levels of PPAR-γ and eNOS significantly (P<0.05). Huaxia shallot preparation could decrease the apoptosis rate of the HUVECs.Conclusion: Ox-LDL may be involved in the initiation and progression of atherosclerosis by injuring the endothelial cells directly and may cause the endothelial dysfunction. Huaxia shallot preparation can protect against Ox-LDL induced endothelial cell injury by up-regulating the protein expressions and mRNA levels of PPAR-γ and eNOS. It suggests that Huaxia shallot preparation may play a role in the prevention and treatment of cardiovascular disease.

Key words: atherosclerosis, endothelium, low-density lipoproteins, nitric-oxide synthase ;peroxisomes, alli-um schoenoprasum

CLC Number: 

  • R972.6

Figure 1

Shape characteristics of human umbilical vein endothelial cells in different groups (phase contrast optical microscope,×100)A: Blank control group; B: Ox-LDL-treated group; C: Huaxia shallot-treated group; D: Pingfu-treated group; E: Salvia dropping pill-treated group; F: Lipitor-treated group."

Table 1

Effects of different drugs on the viability of human umbilical vein endothelial cells impaired by Ox-LDL ($\bar{x}±S$)"

Group n Optical density value
Blank control 8 0.450±0.016
Ox-LDL-treated 8 0.213±0.014*
Huaxia shallot-treated 8 0.381±0.015*
Pingfu-treated 8 0.418±0.017*△▲
Salvia dropping pill-treated 8 0.277±0.016*△▲□
Lipitor-treated 8 0.326±0.019*△▲□■

Table 2

Effects of different drugs on number of human umbilical vein endothelial cells, NO content and SOD activity ($\bar{x}±S$)"

Group n Cell number (1×105/ml) SOD (U/ml) NO (μmol/L)
Blank control 6 38.25±1.71 21.16±7.09 600.75±35.42
Ox-LDL-treated 6 25.00±1.63* 14.42±5.54 265.50±22.35*
Huaxia shallot-treated 6 31.00±0.82* 16.85±6.57 391.75±22.60*
Pingfu-treated 6 34.50±1.29* 18.43±6.28 527.25±22.87*△▲
Salvia dropping pill-treated 6 28.25±0.96* 14.92±6.02 334.50±27.43*△▲□
Lipitor-treated 6 28.75±2.63* 15.01±5.83 335.50±30.54*△▲□

Table 3

Effects of different drugs on cell apoptosis rate tested by AnnexinV-PI method in different groups ($\bar{x}±S$, %)"

Group n Cell apoptosis rate
Blank control 6 8.7±1.5
Ox-LDL-treated 6 26.8±5.9*
Huaxia shallot-treated 6 11.4±3.2
Pingfu-treated 6 10.6±2.9
Salvia dropping pill-treated 6 19.1±4.7
Lipitor-treated 6 16.5±3.8

Figure 2

mRNA expressions of PPAR-γ and eNOS in human umbilical vein endothelial cellsA: PPAR-γ mRNA; B: eNOS mRNA; 0: Marker, 1: Blank control group; 2: Ox-LDL-treated group; 3: Huaxia shallot-treated group; 4: Pingfu-treated group; 5: Salvia dropping pill-treated group; 6: Lipitor-treated group."

Figure 3

Protein expressions of PPAR-γ and eNOS in human umbilical vein endothelial cells A: PPAR-γ protein; B: eNOS protein; 1: Blank control group; 2: Ox-LDL-treated group; 3: Huaxia shallot-treated group; 4: Pingfu-treated group; 5: Salvia dropping pill-treated group; 6: Lipitor-treated group."

[1] Hayashi T, Juliet PA, Miyazaki A , et al. beta1 antagonist and beta2 agonist, celiprolol, restores the impaired endothelial dependent and independent responses and decreASed TNFalpha in rat with type II diabetes[J]. Life Sci, 2007,80(6):592-599
doi: 10.1016/j.lfs.2006.10.018
[2] Cottone S, Mule G, Nardi E , et al. Microalbuminuria and early endothelial activation in essential hypertension[J]. J Hum Hypertens, 2007,21(2):167-172
doi: 10.1038/sj.jhh.1002109 pmid: 17051235
[3] Arbel Y, Dvir D, Feinberg MS , et al. The association between right coronary artery morphology and endothelial function[J]. Int J Cardiol, 2007,115(1):19-23
doi: 10.1016/j.ijcard.2005.12.023 pmid: 16757041
[4] Biro A, Thielens NM, Cervenak L , et al. Modified low density lipoproteins differentially bind and activate the C1 complex of complement[J]. Mol Immunol, 2007,44(6):1169-1177
doi: 10.1016/j.molimm.2006.06.013 pmid: 16938346
[5] Cappello C, Saugel B, Huth KC , et al. Ozonized low density lipoprotein(ozLDL) inhibits NF-kappaB and IRAK-1-ASsociated signaling[J]. Arterioscler Thromb Vasc Biol, 2007,27(1):226-232
doi: 10.1161/01.ATV.0000250615.27795.85 pmid: 17053167
[6] 张介眉, 时绍红, 郝建军 . 搏心通对饲高脂家兔抗氧化损伤、改善内皮功能作用的实验研究[J]. 中医杂志, 2006,47(2):142-143
Zhang Jiemei, Shi ZHaohong, Hao Jianjun , et al. Empirical study of preventing oxidative damage and improving endothelio function of in high-fat feeding rabbit[J]. Zhong Yi Za Zhi, 2006,47(2):142-143
[7] Chen YJ, Wang JS, Chow SE . Resveratrol protects vascular endothelial cell from ox-LDL-induced reduction in antithrombogenic activity[J]. Chin J Physiol, 2007,50(1):22-28
[8] Blaschke F, Caglayan E, Hsueh WA . Peroxisome proliferator-activated receptor gamma agonists: their role AS vasoprotective agents in diabetes[J]. Endocrinol Metab Clin North Am, 2006,35(3):561-574
[9] Barlic J, Zhang Y, Foley JF , et al. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway[J]. Circulation, 2006,114(8):807-819
[1] Fatma Mohamed Hussein Shediwah, Khalid Mohammed Naji, Hussein Saleh Gumaih, Fatima A Alhadi, Amani Lutf Al-Hammami, Myrene Roselyn D'Souza. Antioxidant and antihyperlipidemic activity of Costus speciosus against atherogenic diet-induced hyperlipidemia in rabbits. Journal of Integrative Medicine, 2019, 17(3): 181-191.
[2] Keshav Raj Paudel, Ung-Won Lee, Dong-Wook Kim. Chungtaejeon, a Korean fermented tea, prevents the risk of atherosclerosis in rats fed a high-fat atherogenic diet. Journal of Integrative Medicine, 2016, 14(2): 134-142.
[3] Cheng Huang​. Natural modulators of liver X receptors. Journal of Integrative Medicine, 2014, 12(2): 76-85.
[4] Hong Wang , Jing-tian Ou , Xin Zhao , Ying Guoz , Hao-ping Mao. Vasodilator effect of oroxylin A on thoracic aorta isolated from rats. Journal of Chinese Integrative Medicine, 2012, 10(8): 880-885.
[5] Mei-jiao Mao, Jun-ping Hu, Cong Wang, Yi-yi Zhang, Ping Liu. Effects of Chinese herbal medicine Guanxinkang on expression of PPARγ-LXRα-ABCA1 pathway in ApoE-knockout mice with atherosclerosis. Journal of Chinese Integrative Medicine, 2012, 10(7): 814-820.
[6] Chuan Chen, Hui-ying Chi, Zhi-hua Yu, Jiu-lin Chen . Effects of Chinese herbal medicine Shoushen Granule on telomere length and telomerase activity of peripheral white blood cells and vascular cells in rats with atherosclerosis. Journal of Chinese Integrative Medicine, 2012, 10(6): 667-673.
[7] Mao Mei-jiao, Hu Jun-ping, Chen Fu-rong, Zhang Yi-yi, Liu Ping. Effects of Chinese herbal medicine Guanxinkang on lipid metabolism and serum C-reactive protein, amyloid A protein, and fibrinogen in apolipoprotein E-knockout mice with atherosclerosis. Journal of Chinese Integrative Medicine, 2011, 9(3): 306-312.
[8] Jian-nan Song, Jun-lian Liu, Xiang-zhong Fang, Yuan-hui Hu, Yan Lei, Xiao-hong Niu, Gang Wu, Bao-sheng Chen, Ya-luan Ma, Bing Chen, Hong jin. Relationship between plasma protein expression profiles and states of Zang-Fu organs in patients with phlegm or blood stagnation syndromes due to hyperlipidemia and atherosclerosis. Journal of Chinese Integrative Medicine, 2008, 6(12): 1233-1237.
[9] Lian-qing Sun, Yan Yang, Wei Zheng. Relationship between syndrome differentiation of traditional Chinese medicine and vascular endothelial function in patients with diabetic arterial occlusion of lower extremities. Journal of Chinese Integrative Medicine, 2007, 5(6): 621-624.
[10] Hong Liang, Yu Zhang, Jian-dong Zhang, Jian Gu, Li Ma, Xiao-ling Wang, Wei-gan Shen. Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02. Journal of Chinese Integrative Medicine, 2007, 5(6): 647-650.
[11] Bao-xiang Wang​, Xue-mei Dong​, Ai-min Guo​, Jie Zhang​. Effects of Xuefu Zhuyu Decoction on functions of vascular endothelium in patients with unstable angina pectoris. Journal of Chinese Integrative Medicine, 2006, 4(3): 256-259.
[12] Xu-min Hou, Huan-chun Ni, Xin-ping Luo, Hai-ming Shi, Wei-hu Fan. Effect of Zhenju Jiangya Tablet on the endothelial function of hyperlipidemic rabbits. Journal of Chinese Integrative Medicine, 2004, 2(2): 111-114.
[13] Qin-shan Li, Gui-yu Lou, Min-zhang Qian. Effect of hesperidin and rutin on oxidative modification of high density lipoprotein in vitro. Journal of Chinese Integrative Medicine, 2004, 2(2): 115-116.
[14] Jie Xu, Wei-hu Fan. Effect of salvianolate on migration of human vascular endothelial cells. Journal of Chinese Integrative Medicine, 2003, 1(3): 211-214.
[15] Wen-jian Wang, Zhen-yu Fei, Xiao-dong Fu, Wei-hua Chen, Jian Ying, Feng Tang. Study of an animal model of post-menopausal atherosclerosis in rabbit and observation of the effect of herbal formula of tonifying-kidney on it. Journal of Chinese Integrative Medicine, 2003, 1(2): 113-115.
Full text



[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[3] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[4] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[5] Chan Chen, Yong-mei Meng , Peng Zhang, Juan Wang, Hui-hui Zhao, Shu-zhen Guo , Wei Wang. Diagnosis and treatment rule of traditional Chinese medicine for syndrome factors of chronic congestive heart failure: a study based on Shannon entropy method. Journal of Chinese Integrative Medicine, 2010, 8(11): 1080-1084
[6] Liang-ping Hu , Xiao-lei Bao, Xue Guan. Statistical inference and experimental design of univariate qualitative data of single-group design. Journal of Chinese Integrative Medicine, 2010, 8(11): 1085-1089
[7] Xiao Zhang , Bing-bing Ning , Shuang Ren , Li-jun Zhang , Wen-meng Zhang , Jia-mei Chen , Gao-feng Chen , Hua Zhang , Yong-ping Mu , Ping Liu. Effects of Chinese herbal medicine Xiaopi Pill in preventing rats from dimethylnitrosamine-induced liver fibrosis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1286-1292
[8] Kishan Lal Tiwari, Shailesh Kumar Jadhav, Veenu Joshi. An updated review on medicinal herb genus Spilanthes. Journal of Chinese Integrative Medicine, 2011, 9(11): 1170-1178
[9] Liang-ping Hu, Xiao-lei Bao, Li-xin Tao, Shi-guo Zhou, Xue Guan. Estimation of sample size and testing power (Part 2). Journal of Chinese Integrative Medicine, 2011, 9(11): 1185-1189
[10] Stephen D. Anton, Jonathan Shuster, Christiaan Leeuwenburgh. Investigations of botanicals on food intake, satiety, weight loss and oxidative stress: Study protocol of a double-blind, placebo-controlled, crossover study. Journal of Chinese Integrative Medicine, 2011, 9(11): 1190-1198